Related Experiment Video
Updated: Jul 2, 2026

Location, Dissection, and Analysis of the Murine Stellate Ganglion
Published on: December 22, 2020
Emerging roles of the cGAS/STING pathway in cardiovascular diseases
Wataru Saitoh1, Yasutomi Higashikuni1,2,3,4, Oyunbileg Bavuu1
1Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Insights
Cardiovascular diseases involve inflammation, often triggered by the cyclic GMP-AMP synthase/stimulator of IFN genes (cGAS/STING) pathway. Targeting this pathway shows therapeutic potential for treating cardiovascular diseases.
Area of Science:
- Cardiovascular research
- Immunology
- Molecular biology
Background:
- Cardiovascular diseases (CVDs) are a leading global cause of death.
- Inflammation is a critical factor in CVD development.
- The cyclic GMP-AMP synthase/stimulator of IFN genes (cGAS/STING) pathway is implicated in inflammatory processes.
Purpose of the Study:
- To review the role of self-DNA and the cGAS/STING pathway in CVD pathophysiology.
- To explore the therapeutic potential of targeting the cGAS/STING pathway for CVD treatment.
Main Methods:
- Literature review and synthesis of current research on the cGAS/STING pathway in cardiovascular contexts.
- Analysis of the mechanisms by which self-DNA activates inflammatory signaling in CVD.
Main Results:
- The cGAS/STING pathway recognizes self-DNA, activating downstream inflammatory signaling (TBK1, IRF3, NF-κB).
- Circulating cell-free DNA serves as a biomarker for CVDs.
- The precise contribution of self-DNA to CVD-related inflammation, cell death, and fibrosis requires further elucidation.
Conclusions:
- The cGAS/STING pathway plays a significant role in the inflammatory basis of cardiovascular diseases.
- Targeting the cGAS/STING pathway presents a promising therapeutic strategy for managing CVDs.
Abstract:
Cardiovascular diseases (CVDs) remain the leading cause of mortality and morbidity worldwide, highlighting the need for novel therapeutic approaches. Inflammation plays a key role in CVD pathogenesis, and accumulating evidence has implicated the cyclic GMP-AMP synthase/stimulator of IFN genes (cGAS/STING) pathway in this process. The cGAS/STING pathway recognizes both non-self- and self-DNA, including mitochondrial and nuclear DNA, to activate its downstream proinflammatory signaling molecules, including TANK-binding kinase 1, IFN regulatory factor 3, and NF-κB. Various pathological stressors have been shown to induce self-DNA release into the cytosol and bloodstream from damaged cells in the cardiovascular system, indicating that circulating cell-free DNA is a useful biomarker of CVDs; however, how this contributes to the inflammatory signaling, cell death, and fibrosis that characterize CVDs remains unclear. Here, we discuss the current understanding on the roles of self-DNA and the cGAS/STING pathway in the pathophysiology of CVDs and the therapeutic potential of targeting this pathway.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Two...
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Intracellular Signaling Cascades
G-Protein Gated Ion Channels
Sensory organs,...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Regulation of Angiogenesis and Blood Supply